{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T05:47:41Z","timestamp":1698212861591},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[1989,12]]},"DOI":"10.1007\/bf02306490","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T04:14:29Z","timestamp":1139976869000},"page":"407-413","source":"Crossref","is-referenced-by-count":7,"title":["Recent developments in the prevention and treatment of congenital toxoplasmosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Gordon N","family":"Dutton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02306490_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archopht.1964.00970010074010","volume":"71","author":"TE Acers","year":"1964","unstructured":"Acers TE. Toxoplasmic retinochoroiditis: a double blind therapeutic study. Arch Ophthalmol 1964; 71: 58\u201362.","journal-title":"Arch Ophthalmol"},{"key":"BF02306490_CR2","first-page":"160","volume":"50","author":"CA Alford","year":"1974","unstructured":"Alford CA, Stagno S, Reynolds DW. Congenital toxoplasmosis: clinical, laboratory and therapeutic considerations with special reference to subclinical disease. Bull NY Acad Med 1974; 50: 160\u2013181.","journal-title":"Bull NY Acad Med"},{"key":"BF02306490_CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1172\/JCI112837","volume":"79","author":"CJ Allegra","year":"1987","unstructured":"Allegra CJ, Kovacs JA, Drake JC, Chabner BA, Masur H. Potentin vitro andin vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate. J Clin Invest 1987; 79: 478\u201382.","journal-title":"J Clin Invest"},{"key":"BF02306490_CR4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/156.5.828","volume":"156","author":"FG Araujo","year":"1987","unstructured":"Araujo FG, Guptill DR, Remington JS.In vivo activity of piritrexin againstToxoplasma gondii. J Infect Dis 1987; 156: 828\u201330.","journal-title":"J Infect Dis"},{"key":"BF02306490_CR5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/AAC.32.5.755","volume":"32","author":"FG Araujo","year":"1988","unstructured":"Araujo FG, Guptill DR, Remington JS. Azithromycin, a macrolide antibiotic with potent activity againstToxoplasma gondii. Antimicrob Agents Chemother 1988; 32: 755\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02306490_CR6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.5.6.647","volume":"5","author":"FG Araujo","year":"1974","unstructured":"Araujo FG, Remington JS. Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrob Chemother 1974; 5: 647\u201351.","journal-title":"Antimicrob Chemother"},{"key":"BF02306490_CR7","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.141.10.3584","volume":"141","author":"JL Burg","year":"1988","unstructured":"Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC. Molecular analysis of the gene encoding the major surface antigen ofToxoplasma gondii. J Immunol 1988; 141: 3584\u201391.","journal-title":"J Immunol"},{"key":"BF02306490_CR8","first-page":"618","volume":"135","author":"AO Carter","year":"1986","unstructured":"Carter AO, Frank JW. Congenital toxoplasmosis: epidemiologic features and control. Can Med Assoc J 1986; 135: 618\u201323.","journal-title":"Can Med Assoc J"},{"key":"BF02306490_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/AAC.30.2.323","volume":"30","author":"J Chan","year":"1986","unstructured":"Chan J, Luft BJ. Activity of roxithromycin (Ru28965) a macrolide againstToxoplasma gondii infection in mice. Antimicrob Agents Chemother 1986; 30: 323\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl B","key":"BF02306490_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/20.suppl_B.69","volume":"20","author":"HR Chang","year":"1987","unstructured":"Chang HR, Pech\u00e8re J-CF. Activity of roxithromycin againstToxoplasma gondii in murine models. J Antimicrob Chemother 1987; 20 Suppl B: 69\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"BF02306490_CR11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/AAC.32.4.524","volume":"32","author":"HR Chang","year":"1988","unstructured":"Chang HR, Pech\u00e8re J-CF. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin (CP-62,993) and (A-56268) onToxoplasma gondii. Antimicrob Agents Chemother 1988; 32: 524\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02306490_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/23.2.229","volume":"23","author":"HR Chang","year":"1989","unstructured":"Chang HR, Pech\u00e8re J-C. In vitro toxoplasmacidal activity of cationic electron carriers. J Antimicrob Chemother 1989; 23: 229\u201336.","journal-title":"J Antimicrob Chemother"},{"key":"BF02306490_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jac\/22.3.359","volume":"22","author":"HR Chang","year":"1988","unstructured":"Chang HR, Rudareanu FC, Pech\u00e8re J-C. Activity of A-56268 (TE-031) a new macrolide againstToxoplasma gondii in mice. J Antimicrob Chemother 1988; 22: 359\u201361.","journal-title":"J Antimicrob Chemother"},{"key":"BF02306490_CR14","first-page":"115","volume-title":"Handbook of Clinical Neurology Vol 35. Infections of the nervous system","author":"J Couvreur","year":"1978","unstructured":"Couvreur J, Desmonts G. Toxoplasmosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology Vol 35. Infections of the nervous system. Amsterdam. North Holland Publishing Company 1978: 115\u201341."},{"key":"BF02306490_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM198802043180502","volume":"318","author":"F Daffos","year":"1988","unstructured":"Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. New Eng J Med 1988; 318: 271\u20135.","journal-title":"New Eng J Med"},{"key":"BF02306490_CR16","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1001\/archinte.1988.00380110109023","volume":"148","author":"BR Dannemann","year":"1988","unstructured":"Dannemann BR, Israelski DM, Remington JS. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med 1988; 148: 2477\u201382.","journal-title":"Arch Intern Med"},{"key":"BF02306490_CR17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-3024.1988.tb00242.x","volume":"10","author":"F Darcy","year":"1988","unstructured":"Darcy F, Deslee D, Dantoro F, Charif H, Auriault C, Decoster A, Dequesne V, Capron A. Induction of a protective antibody dependent response again toxoplasmosis byin vitro excreted\/secreted antigens from tachyzoites ofToxoplasms gondii. Parasite Immunology 1988; 10: 553\u201368.","journal-title":"Parasite Immunology"},{"key":"BF02306490_CR18","first-page":"61","volume-title":"Proceedings of the Sixth European Congress on Perinatal Medicine, Vienna, 1978","author":"H Roever-Bonnet De","year":"1979","unstructured":"De Roever-Bonnet H, Koppe JG, Loewer-Sieger DH. Follow-up of children with congenitalToxoplasma infection and children who became serologically negative after 1 year of age, all born in 1964\u20131965. In: Thalhammer O, Baumgarten K, Pollak A. eds. Proceedings of the Sixth European Congress on Perinatal Medicine, Vienna, 1978. Thieme, Stuttgart 1979: 61\u201375."},{"key":"BF02306490_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF01962355","volume":"7","author":"F Derouin","year":"1988","unstructured":"Derouin F, Thulliez P, Candolfi E, Daffos F, Forestier F. Early pre-natal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis 1988; 7: 423\u20134.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BF02306490_CR20","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM197405162902003","volume":"290","author":"G Desmonts","year":"1974","unstructured":"Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Eng J Med 1974; 290: 1110\u20136.","journal-title":"N Eng J Med"},{"key":"BF02306490_CR21","first-page":"146","volume":"50","author":"G Desmonts","year":"1974","unstructured":"Desmonts G, Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull NY Acad Med 1974; 50: 146\u201359.","journal-title":"Bull NY Acad Med"},{"key":"BF02306490_CR22","first-page":"51","volume-title":"Proceedings of the Sixth European Congress of Perinatal Medicine, Vienna, 1978","author":"G Desmonts","year":"1979","unstructured":"Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of congenital disease. In: Thalhammer O, Baumgarten K, Pollak A. eds. Proceedings of the Sixth European Congress of Perinatal Medicine, Vienna, 1978. Thieme, Stuttgart 1979, 51\u201360."},{"key":"BF02306490_CR23","first-page":"805","volume":"31","author":"G Desmonts","year":"1984","unstructured":"Desmonts G, Couvreur J. Toxoplasmose congenitale. \u00c9tude prospective de l'issue de la grossesse chez 542 femmes atteintes de toxoplasmose acquise en course de gestation. Ann Pediatr (Paris) 1984; 31: 805\u20139.","journal-title":"Ann Pediatr (Paris)"},{"key":"BF02306490_CR24","first-page":"404","volume":"105","author":"GN Dutton","year":"1986","unstructured":"Dutton GN. The causes of tissue damage in toxoplasmic retinochoroiditis. Trans Ophthal Soc UK 1986; 105: 404\u201312.","journal-title":"Trans Ophthal Soc UK"},{"key":"BF02306490_CR25","first-page":"529","volume":"5","author":"DE Eyles","year":"1955","unstructured":"Eyles DE, Coleman N. Evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot Chemother 1955; 5: 529\u201339.","journal-title":"Antibiot Chemother"},{"key":"BF02306490_CR26","first-page":"228","volume":"50","author":"JK Frenkel","year":"1974","unstructured":"Frenkel JK. Breaking the transmission chain ofToxoplasma a program for the prevention of human toxoplasmosis. Bull NY Acad Med 1974; 50: 228\u201335.","journal-title":"Bull NY Acad Med"},{"key":"BF02306490_CR27","first-page":"354","volume":"19","author":"JK Frenkel","year":"1985","unstructured":"Frenkel JK. Immunity to toxoplasmosis. Pan Am Health Org Bull 1985; 19: 354\u201367.","journal-title":"Pan Am Health Org Bull"},{"key":"BF02306490_CR28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/infdis\/126.6.664","volume":"126","author":"JK Frenkel","year":"1972","unstructured":"Frenkel JK, Dubey JP. Toxoplasmosis and its prevention in cats and man. J Infect Dis 1972; 126: 664\u201373.","journal-title":"J Infect Dis"},{"key":"BF02306490_CR29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(88)90264-4","volume":"2","author":"LC Fuith","year":"1988","unstructured":"Fuith LC, Reibnegger G, Honlinger M, Wachter H. Screening for toxoplasmosis in pregnancy. Lancet 1988; 2: 1196.","journal-title":"Lancet"},{"key":"BF02306490_CR30","first-page":"88","volume":"16","author":"CL Giles","year":"1971","unstructured":"Giles CL. Pyrimethamine (Daraprim) and the treatment of toxoplasmic uveitis. Survey of Ophthalmology 1971; 16: 88\u201391.","journal-title":"Survey of Ophthalmology"},{"key":"BF02306490_CR31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0002-9343(87)90151-3","volume":"82","author":"HW Haverkos","year":"1987","unstructured":"Haverkos HW. Assessment of therapy for toxoplasma encephalitis. The TE Study Group. Am J Med 1987; 82: 907\u201314.","journal-title":"Am J Med"},{"key":"BF02306490_CR32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/AAC.31.2.346","volume":"31","author":"JM Hofflin","year":"1987","unstructured":"Hofflin JM, Remington JS. In vivo synergism of roxithromycin (RV965) and interferon againstToxoplasma gondii. Antimicrob Agents Chemother 1987; 31: 346\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02306490_CR33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/AAC.31.4.492","volume":"31","author":"JM Hofflin","year":"1987","unstructured":"Hofflin JM, Remington JS. Clindamycin in a murine model of toxoplasmic encephalitis. Antimicrob Agents Chemother 1987; 31: 492\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02306490_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-4453(88)93847-9","volume":"16","author":"RE Holliman","year":"1988","unstructured":"Holliman RE. Toxoplasmosis and the acquired immune deficiency syndrome. J Infect 1988; 16: 121\u20138.","journal-title":"J Infect"},{"key":"BF02306490_CR35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/AAC.33.1.30","volume":"33","author":"DM Israelski","year":"1989","unstructured":"Israelski DM, Tom C, Remington JS. Zidovudine antagonizes the action of pyrimethamine in experimental infection withToxoplasma gondii. Antimicrob Agents Chemother 1989; 33: 30\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02306490_CR36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/icb.1986.37","volume":"64","author":"AM Johnson","year":"1986","unstructured":"Johnson AM, Dubey JP, Dame JB. Purification and characterization of theToxoplasma gondii tachyzoite DNA. Aust J Exp Biol Med Sci 1986; 64: 351\u20135.","journal-title":"Aust J Exp Biol Med Sci"},{"key":"BF02306490_CR37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0014-4894(87)90173-1","volume":"63","author":"AM Johnson","year":"1987","unstructured":"Johnson AM, Illana S, Dubey JP, Dame JB.Toxoplasma gondii andHammondia hammondi: DNA comparison using cloned RNA gone probes. Exp Parasitol 1987; 63: 272\u20138.","journal-title":"Exp Parasitol"},{"key":"BF02306490_CR38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)92443-9","volume":"2","author":"DHM Joynson","year":"1988","unstructured":"Joynson DHM, Payne R. Screening for Toxoplasma in pregnancy. Lancet 1988; 2: 795\u20136.","journal-title":"Lancet"},{"key":"BF02306490_CR39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0140-6736(86)90785-3","volume":"1","author":"JG Koppe","year":"1986","unstructured":"Koppe JG, Loewer-Sieger DH, De Roever-Bonnet H. Results of 20 years follow-up of congenital toxoplasmosis. Lancet 1986; 1: 254\u20135.","journal-title":"Lancet"},{"key":"BF02306490_CR40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/infdis\/155.5.1027","volume":"155","author":"JA Kovacs","year":"1987","unstructured":"Kovacs JA, Allegra CJ, Chabner BA, Swan JC, Drake J, Lunde M, Parrillo JE, Masur H. Potent effect of trimetrexate: a lipid-soluble antifolate onToxoplasma gondii. J Infect Dis 1987; 155: 1027\u201332.","journal-title":"J Infect Dis"},{"key":"BF02306490_CR41","first-page":"265","volume":"5","author":"R Lambotte","year":"1976","unstructured":"Lambotte R. Toxoplasmose cong\u00e9nitale: \u00e9valuation du b\u00e9n\u00e9fice th\u00e9rapeutique pr\u00e9natal. J Gynecol Obstet Biol Reprod (Paris) 1976; 5: 265\u20139.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"BF02306490_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0002-9343(88)90014-9","volume":"84","author":"C Leport","year":"1988","unstructured":"Leport C, Raffi F, Matherson S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL. Treatment of central nervous system toxoplasmosis with pyrimethamine\/sulfadiazine combination in 35 patients with the acquired immunodefficiency syndrome. Efficacy of long-term continuous therapy. Amer J Med 1988; 84: 94\u2013100.","journal-title":"Amer J Med"},{"key":"BF02306490_CR43","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4049\/jimmunol.140.5.1632","volume":"140","author":"R McLeod","year":"1988","unstructured":"McLeod R, Frenkel JK, Estes RG, Mack DG, Eisenhauer PB, Gibori G. Subcutaneous and intestinal vaccination with tachyzoites ofToxoplasma gondii and acquisition of immunity to peroral and congenital Toxoplasma challenge. J Immunol 1988; 140: 1632\u20137.","journal-title":"J Immunol"},{"key":"BF02306490_CR44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.1973.22.14","volume":"22","author":"PRB McMaster","year":"1973","unstructured":"McMaster PRB, Powers KG, Finerty JF, Lunde MN. The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg 1973; 22: 14\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"BF02306490_CR45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/inf.1975.7.issue-1.13","volume":"1","author":"R Norrby","year":"1975","unstructured":"Norrby R, Eilard T, Svedham A, Lycke E. Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole. Scand J Infect Dis 1975; 1: 72\u20135.","journal-title":"Scand J Infect Dis"},{"key":"BF02306490_CR46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jac\/5.3.244","volume":"5","author":"FJ Nye","year":"1979","unstructured":"Nye FJ. Treating toxoplasmosis. J Antimicrob Chemother 1979; 5: 244\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"BF02306490_CR47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bjo.40.10.577","volume":"40","author":"ES Perkins","year":"1956","unstructured":"Perkins ES, Smith CH, Schofield PB. Treatment of uveitis with pyrimethamine (Daraprim). Br J Opthalmol 1956; 40: 577\u201386.","journal-title":"Br J Opthalmol"},{"key":"BF02306490_CR48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00130002","volume":"12","author":"GA Peyman","year":"1988","unstructured":"Peyman GA, Charles HC, Liu KR, Khoobehi B, Niesman M. Intravitreal liposome encapsulated drugs: a preliminary report. Int Ophthalmol 1988; 12: 175\u2013182.","journal-title":"Int Ophthalmol"},{"key":"BF02306490_CR49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0014-4894(88)90133-6","volume":"65","author":"ER Pfefferkorn","year":"1988","unstructured":"Pfefferkorn ER, Eckel ME, McAdams E. Toxoplasma gondii:in vivo andin vitro studies of a mutant resistant to arprinocid-N-oxide. Exp Parasitol 1988; 65: 282\u20139.","journal-title":"Exp Parasitol"},{"key":"BF02306490_CR50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(88)80377-2","volume":"85","author":"KVI Rolston","year":"1988","unstructured":"Rolston KVI. Clindamycin in cerebral toxoplasmosis. Am J Med 1988; 85: 284.","journal-title":"Am J Med"},{"key":"BF02306490_CR51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0002-9343(87)90769-8","volume":"83","author":"KV Rolston","year":"1987","unstructured":"Rolston KV, Hoy J. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Am J Med 1987; 83: 551\u20134.","journal-title":"Am J Med"},{"key":"BF02306490_CR52","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1471-0528.1972.tb11897.x","volume":"79","author":"CF Ruoss","year":"1972","unstructured":"Ruoss CF, Bourne GL. Toxoplasmosis in pregnancy. J Obstet Gynaecol Br Commonw 1972; 79: 1115\u20138.","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"BF02306490_CR53","unstructured":"Saari KM, P\u00e4iv\u00f6nsalo T, Partti E. Argon laser coagulation in the treatment of recurrent active toxoplasmic retinochoroiditis. In: Saari KM. ed. Uveitis Update. Elsevier Science Publishers 1984: 529\u201338."},{"key":"BF02306490_CR54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(88)90111-0","volume":"2","author":"RC Salmon","year":"1988","unstructured":"Salmon RC. Screening for Toxoplasma in pregnancy. The Lancet 1988; 2: 1085.","journal-title":"The Lancet"},{"key":"BF02306490_CR55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archopht.1966.00970050023006","volume":"75","author":"HF Spalter","year":"1966","unstructured":"Spalter HF, Campbell CJ, Noyori KS, Rittler CM, Koester CJ. Prophylactic photocoagulation of recurrent toxoplasmic retinochoroiditis. A preliminary report. Arch Ophthalmol 1966; 75: 21\u201331.","journal-title":"Arch Ophthalmol"},{"key":"BF02306490_CR56","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archopht.1979.01020010286021","volume":"97","author":"KF Tabbara","year":"1979","unstructured":"Tabbara KF, Dy-Liacco J, Nozik RA, O'Connor GR, Blackman J. Clindamycin in chronic toxoplasmosis. Effect of periocular injections on recoverability of organisms from healed lesions in the rabbit eye. Arch Ophthalmol 1979; 97: 542\u20134.","journal-title":"Arch Ophthalmol"},{"key":"BF02306490_CR57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1974.01010010252017","volume":"92","author":"KF Tabbara","year":"1974","unstructured":"Tabbara KF, Nozik RA, O'Connor GR. Clindamycin effects on experimental ocular toxoplasmosis in the rabbit. Arch Ophthalmol 1974; 92: 244\u20137.","journal-title":"Arch Ophthalmol"},{"key":"BF02306490_CR58","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1056\/NEJM198808113190615","volume":"319","author":"JM Thorp","year":"1988","unstructured":"Thorp JM, Seeds JW, Herbert WNP, Bowes WA, Maslow AS, Cefalo RC, Chescheir N, Katz VL. Prenatal management and congenital toxoplasmosis. New Engl J Med 1988; 319: 372\u20133.","journal-title":"New Engl J Med"},{"issue":"suppl A","key":"BF02306490_CR59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/23.suppl_A.77","volume":"23","author":"CU Tuazon","year":"1989","unstructured":"Tuazon CU. Toxoplasmosis in AIDS patients. J Antimicrob Chemother 1989; 23 suppl A: 77\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"BF02306490_CR60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4269\/ajtmh.1987.36.509","volume":"36","author":"C Wanke","year":"1987","unstructured":"Wanke C, Tuazon CU, Kovaks A, Dina T, Davis DO, Burton DK, Lunde M, Levy C.Toxoplasma encephalitis in patients with acquired immune deficiency syndrome. Am J Trop Med Hyg 1987; 36: 509\u201316.","journal-title":"Am J Trop Med Hyg"},{"key":"BF02306490_CR61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0163-4453(81)90773-8","volume":"3","author":"KAB Williams","year":"1981","unstructured":"Williams KAB, Scott JM, MacFarlane DF. Congenital toxoplasmosis: a prospective study in the West of Scotland. J Infect 1981; 3: 219\u201329.","journal-title":"J Infect"},{"key":"BF02306490_CR62","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","volume":"66","author":"CB Wilson","year":"1980","unstructured":"Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenitalToxoplasma infection. Pediatrics 1980; 66: 767\u201374.","journal-title":"Pediatrics"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02306490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02306490\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02306490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T13:49:50Z","timestamp":1683380990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02306490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["BF02306490"],"URL":"https:\/\/doi.org\/10.1007\/bf02306490","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,12]]}}}